Shemin D, Dworkin L D
Department of Medicine, Rhode Island Hospital, Providence 02903, USA.
Curr Opin Nephrol Hypertens. 1997 Mar;6(2):128-32. doi: 10.1097/00041552-199703000-00004.
Sodium balance in patients with renal failure varies with the severity and clinical manifestations of renal disease. Progressive chronic renal insufficiency is typified by an adaptive increase in the sodium excretion rate per nephron as the total glomerular filtration rate declines. This increase is caused, at least in part, by the effect of atrial natriuretic peptide and other natriuretic peptides, whose release is augmented in the setting of volume expansion and renal failure. However, exogenous administration of natriuretic peptides in clinical chronic and acute renal disease does not consistently increase renal sodium excretion. As the glomerular filtration rate progressively declines towards end-stage renal disease, total renal sodium excretion eventually decreases, and extracellular volume expansion, hypertension, and edema develop. Sodium removal, induced by high dose diuretics or via convective ultrafiltration during dialysis, is necessary to decrease the extracellular volume to normal.
肾衰竭患者的钠平衡随肾脏疾病的严重程度和临床表现而变化。进行性慢性肾功能不全的典型表现是,随着肾小球滤过率的总体下降,单个肾单位的钠排泄率适应性增加。这种增加至少部分是由心房利钠肽和其他利钠肽的作用引起的,在容量扩张和肾衰竭的情况下,它们的释放会增加。然而,在临床慢性和急性肾脏疾病中外源性给予利钠肽并不能持续增加肾脏钠排泄。随着肾小球滤过率逐渐下降至终末期肾病,肾脏总钠排泄最终会减少,继而出现细胞外液量扩张、高血压和水肿。通过大剂量利尿剂或透析期间的对流超滤来清除钠,对于将细胞外液量降至正常水平是必要的。